Skip to main content

SELECT MEDICAL HOLDINGS CORP

corporate_fare Company Profile

SELECT MEDICAL HOLDINGS CORP

SEM·NYSE·Healthcare·CIK 0001320414

SELECT MEDICAL HOLDINGS CORP operates as one of the largest providers of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States, based on the number of facilities. The company began operations in 1997. As of December 31, 2025, SELECT MEDICAL HOLDINGS CORP had operations in 39 states and the District of Columbia. Specifically, it operated 104 critical illness recovery hospitals in 28 states, 38 rehabilitation hospitals in 15 states, and 1,917 outpatient rehabilitation clinics in 39 states and the District of Columbia. The company's reportable segments are: (i) the critical illness recovery hospital segment, (ii) the rehabilitation hospital segment, and (iii) the outpatient rehabilitation segment. For the year ended December 31, 2025, SELECT MEDICAL HOLDINGS CORP generated total revenue of $5,452.8 million. Approximately 45% of this revenue came from the critical illness recovery hospital segment, approximately 24% from the rehabilitation hospital segment, and approximately 24% from the outpatient rehabilitation segment. Other revenue was recognized from employee leasing services provided to the Company's non-consolidating subsidiaries. The critical illness recovery hospital segment focuses on patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment serves patients requiring intensive physical rehabilitation care. Patients are typically admitted to both critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. On November 25, 2024, Select completed a tax-free distribution of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc., a previously wholly-owned subsidiary, to its stockholders, and no longer owns any shares of Concentra common stock.

SELECT MEDICAL HOLDINGS CORP (NYSE:SEM) is a publicly traded company in the Healthcare sector. Wiseek monitors SEM SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Definitive Proxy Filed for $16.50/Share Take-Private Merger; Shareholder Vote Set for June 26
  • Amendment Filed for Going-Private Transaction Statement
  • Select Medical Files Proxy for $16.50/Share Go-Private Vote, Details Insider Rollovers
  • Select Medical Signs Definitive Merger Agreement at $16.50/Share; Q1 Revenue Up 5%, EPS Declines
  • Select Medical Holdings Corp to be Acquired for $16.50/Share in Definitive Merger Agreement

monitoring Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.45B
Net Income
$146.22M
Diluted EPS
$1.16
Op. Cash Flow
$346.47M
Free Cash Flow
$117.24M
Operating Income
$336.17M
Cash & Equivalents
$26.52M
Debt / Equity
0.00×
Net Margin
2.7%
Shares Outstanding
124.02M sh
Source: 10-K · filed 2026-02-19 · accession 0001320414-26-000007

supervised_user_circle Insider Transactions

  • 2026-05-04 Breighner Robert G. JR SENIOR VICE PRESIDENT Officer
    Tax/exercise cost 1.33K sh $21.87K @ $16.44
  • 2026-04-30 CHERNOW DAVID S Vice Chairman Officer · Director
    Tax/exercise cost 22.59K sh $370.64K @ $16.41
  • 2026-04-28 Frist William H. Director
    Grant/Award 1.09K sh $18K @ $16.45
  • 2026-02-11 Frist William H. Director
    Grant/Award 1.11K sh $18K @ $16.23
  • 2025-11-01 Malatesta Michael F CHIEF FINANCIAL OFFICER Officer
    Tax/exercise cost 7.36K sh $101.75K @ $13.83
  • 2025-11-01 Duggan John F. Executive Vice President Officer
    Tax/exercise cost 4.87K sh $67.28K @ $13.83
  • 2025-10-28 Frist William H. Director
    Grant/Award 1.27K sh $18K @ $14.22
  • 2025-10-28 Weigl Christopher CHIEF ACCOUNTING OFFICER Officer
    Grant/Award 20K sh
  • 2025-10-28 Duggan John F. Executive Vice President Officer
    Grant/Award 50K sh
  • 2025-08-01 JACKSON MARTIN F EXECUTIVE VICE PRESIDENT Officer
    Tax/exercise cost 29.46K sh $370.31K @ $12.57
  • 2025-08-01 TARVIN MICHAEL E EXECUTIVE VICE PRESIDENT Officer
    Tax/exercise cost 19.64K sh $246.87K @ $12.57
  • 2025-08-01 CHERNOW DAVID S CEO Officer · Director
    Tax/exercise cost 49.1K sh $617.19K @ $12.57
  • 2025-08-01 Saich John A. EXECUTIVE VICE PRESIDENT Officer
    Tax/exercise cost 21.75K sh $273.33K @ $12.57
  • 2025-08-01 Mullin Thomas P CO-PRESIDENT Officer
    Tax/exercise cost 22.05K sh $277.11K @ $12.57
  • 2025-08-01 Rusignuolo Brian R. Chief Information Officer Officer
    Tax/exercise cost 14.68K sh $184.53K @ $12.57
  • 2025-07-29 JACKSON MARTIN F EXECUTIVE VICE PRESIDENT Officer
    Grant/Award 150K sh
  • 2025-07-29 TARVIN MICHAEL E EXECUTIVE VICE PRESIDENT Officer
    Grant/Award 100K sh
  • 2025-07-29 CHERNOW DAVID S CEO Officer · Director
    Grant/Award 250K sh
  • 2025-07-29 CARSON RUSSELL L Director
    Grant/Award 14.04K sh
  • 2025-07-29 TAVENNER MARILYN B Director
    Grant/Award 14.04K sh
From SEC Form 4 + 5 (insider beneficial-ownership filings) · last 12 months · view all on SEC EDGAR ↑
$16.52
52-week range $11.65 – $16.99
Market cap
$2.05B
Volume
4.5M (2.8× avg)
3-mo avg 1.6M
Price snapshot as of 2026-05-20 21:44 UTC (Market snapshot (POST))

show_chartPrice Chart

Loading chart...

feed SEM - Latest Insights

SEM
May 19, 2026, 8:43 PM EDT
Filing Type: DEFM14A
Importance Score:
9
SEM
May 15, 2026, 2:24 PM EDT
Filing Type: SC 13E3/A
Importance Score:
7
SEM
May 15, 2026, 12:59 PM EDT
Filing Type: PRER14A
Importance Score:
9
SEM
Apr 30, 2026, 4:41 PM EDT
Source: Wiseek News
Importance Score:
9
SEM
Apr 30, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
10
SEM
Apr 30, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
7
SEM
Apr 15, 2026, 9:25 AM EDT
Filing Type: SC 13E3
Importance Score:
10
SEM
Apr 15, 2026, 8:37 AM EDT
Filing Type: PREM14A
Importance Score:
9
SEM
Mar 04, 2026, 8:40 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
SEM
Mar 03, 2026, 9:01 AM EST
Filing Type: DEFA14A
Importance Score:
9
SEM
Mar 03, 2026, 8:58 AM EST
Filing Type: 8-K
Importance Score:
9
SEM
Mar 02, 2026, 6:48 PM EST
Source: Dow Jones Newswires
Importance Score:
7
SEM
Mar 02, 2026, 6:45 PM EST
Source: Dow Jones Newswires
Importance Score:
9
SEM
Feb 23, 2026, 7:26 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
SEM
Feb 20, 2026, 5:26 PM EST
Filing Type: PRE 14A
Importance Score:
8
SEM
Feb 19, 2026, 4:48 PM EST
Filing Type: 10-K
Importance Score:
8
SEM
Feb 19, 2026, 4:41 PM EST
Filing Type: 8-K
Importance Score:
9